Advertisement
Advertisement
U.S. markets close in 1 hour 26 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
19.20+0.29 (+1.53%)
As of 02:33PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close18.91
Open18.96
Bid19.14 x 800
Ask19.18 x 1300
Day's Range18.60 - 19.31
52 Week Range11.30 - 34.51
Volume115,792
Avg. Volume597,109
Market Cap1.187B
Beta (5Y Monthly)2.15
PE Ratio (TTM)10.67
EPS (TTM)1.80
Earnings DateSep 06, 2022 - Sep 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est26.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
27% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CDMO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Avid Bioservices, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/13/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more
  • Insider Monkey

    Is Avid Bioservices (CDMO) a Worthy Investment Pick?

    Laughing Water Capital, an investment management firm, published its second-quarter 2022 investor letter – a copy of which can be downloaded here. For Q2 2022 Class A interests in Laughing Water Capital returned approximately -19.4%, bringing our year-to-date returns to approximately -29.5%. The SP500 and R2000 returned -16.1% and -17.2% for the quarter, bringing year-to-date […]

  • Insider Monkey

    Is Avid Bioservices (CDMO) a Great Buy?

    Investment management company Laughing Water Capital released its second quarter investor letter 2022, a copy of the same can be downloaded here. In the second quarter, the fund returned -19.4%, which brings the year-to-date return to -29.5%. The letter discussed the reasons for the underperformance of its portfolios. S&P 500 & Russell 2000 also underperformed in […]

  • Benzinga

    Read How Avid Bioservices Fared In Q4

    View more earnings on CDMOSee more from BenzingaNovartis' Tislelizumab Extends Overall Survival In Late-Stage Esophageal Cancer StudyNovartis Resumes Production, Delivery Of Radioligand Therapy MedicinesDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement
Advertisement